000 | 00939 a2200301 4500 | ||
---|---|---|---|
005 | 20250512010201.0 | ||
264 | 0 | _c19850705 | |
008 | 198507s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(85)92408-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGlasky, A J | |
245 | 0 | 0 |
_aInosine pranobex. _h[electronic resource] |
260 |
_bLancet (London, England) _cMay 1985 |
||
300 |
_a1103-4 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHerpes Genitalis _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInosine _xanalogs & derivatives |
650 | 0 | 4 |
_aInosine Pranobex _xtherapeutic use |
650 | 0 | 4 | _aMale |
700 | 1 | _aGalli, M | |
700 | 1 | _aLassus, A | |
700 | 1 | _aSalo, O | |
773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8437 _gp. 1103-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(85)92408-0 _zAvailable from publisher's website |
999 |
_c2588116 _d2588116 |